It’s getting a little too hot in the kitchen for Martha Stewart.
Still under fire for selling $227,824 worth of ImClone stock the day before the company’s cancer drug was rejected by the Food and Drug Administration, Stewart opted to cancel her Wednesday appearance on CBS’ “The Early Show.”
That Dec. 27 stock sale has been the recipe for a flurry of negative press regarding Stewart, as congressional investigators check out any prospect of insider trading.
The goddess of all things domestic showed up for her “Early Show” stint last week, but anchor Jane Clayson subjected her to a flurry of questions regarding the ImClone stock sale.
In one of this year’s most bizarre TV moments, Stewart — with sharp knife in hand — frantically chopped a cabbage head while telling Clayson she would be exonerated of any “ridiculousness.” Asked further about the charges, Stewart said she wanted to focus on her salad.
Stewart’s syndicated “Martha Stewart Living” strip continues to air on most CBS-owned stations. It’s unclear when Stewart might opt to return to her regular stint on the “Early Show.” A CBS News spokesperson was unavailable for comment.